Adverum Biotechnologies, Inc. (NASDAQ:ADVM) Receives $27.83 Average Target Price from Analysts
Shares of Adverum Biotechnologies, Inc. (NASDAQ:ADVM – Get Free Report) have been assigned an average recommendation of “Moderate Buy” from the six ratings firms that are covering the stock, MarketBeat reports. One analyst has rated the stock with a hold rating and five have issued a buy rating on the company. The average 1-year price […]
Shares of Adverum Biotechnologies, Inc. (NASDAQ:ADVM – Get Free Report) have been assigned an average recommendation of “Moderate Buy” from the six ratings firms that are covering the stock, MarketBeat reports. One analyst has rated the stock with a hold rating and five have issued a buy rating on the company. The average 1-year price […]
